These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 992908)

  • 1. Tumor antigen extracts stimulate cytotoxicity against unrelated target cells.
    Lopez DM; Sigel MM
    Int J Cancer; 1976 Dec; 18(6):808-12. PubMed ID: 992908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of a B lymphocyte population with ADCC effector function in mammary tumor bearing mice.
    Padmanabhan RR; Paul RD; Watson GA; Lopez DM
    J Leukoc Biol; 1988 Jun; 43(6):509-19. PubMed ID: 3259973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. I. Induction of regulatory macrophages in normal mice by the in vivo administration of rGM-CSF.
    Fu YX; Watson GA; Kasahara M; Lopez DM
    J Immunol; 1991 Jan; 146(2):783-9. PubMed ID: 1824777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purified membrane fractions from mammary tumor cells elicit biological reactivity in in vitro cell-mediated immune reactions.
    Buessow SC; Caldwell K; Fletcher MA; Lopez DM
    Eur J Cancer Clin Oncol; 1982 Jun; 18(6):595-604. PubMed ID: 6889532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative assay for tumor antigen based on inhibition of cytotoxicity of sensitized lymphocytes.
    Huber S; Lucas ZJ
    Int J Cancer; 1979 Feb; 23(2):224-32. PubMed ID: 83968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor.
    Sotomayor EM; Fu YX; Lopez-Cepero M; Herbert L; Jimenez JJ; Albarracin C; Lopez DM
    J Immunol; 1991 Oct; 147(8):2816-23. PubMed ID: 1918995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens.
    Kedar E; Bonavida B
    J Immunol; 1975 Nov; 115(5):1301-8. PubMed ID: 51889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incompatibility at irrelevant H-2 specificities augments in vivo stimulation of alloaggressive cells.
    Jorgensen PN
    Scand J Immunol; 1975; 4(4):373-82. PubMed ID: 52889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the effector cells mediating an "innocent bystander" cytotoxicity reaction induced by a syngeneic mammary adenocarcinoma in mice.
    Paul RD; Padmanabhan R; Lopez DM
    Cancer Res; 1984 Oct; 44(10):4480-6. PubMed ID: 6467207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dependence of initiation of an innocent bystander cytotoxicity reaction on the association of viral antigens and tumor cell membranes in mice.
    Lopez DM; Lopez PF; Parks WP; Paul RD
    J Natl Cancer Inst; 1986 May; 76(5):923-31. PubMed ID: 2871214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediation of immune responses to tumor antigens in vitro by immune RNA.
    Kern DH; Drogemuller CR; Pilch YH
    Ann N Y Acad Sci; 1976; 276():278-302. PubMed ID: 1071964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK cells from mammary tumor bearing mice do not exert natural killer activity but function as antibody dependent cellular cytotoxicity effectors.
    Rivera LM; Lopez DM
    Anticancer Res; 1993; 13(1):177-84. PubMed ID: 8476211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response to a syngeneic mammary adenocarcinoma. II. In vitro generation of cytotoxic lymphocytes.
    Kuperman O; Fortner GW; Lucas ZJ
    J Immunol; 1975 Nov; 115(5):1277-81. PubMed ID: 51887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro detection of immune responses to MTV-induced mammary tumors: activity of spleen cell preparations from both MTV-free and MTV-infected mice.
    Blair PB; Lane MA; Yagi MJ
    J Immunol; 1974 Feb; 112(2):693-705. PubMed ID: 4360546
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of cytotoxic effector cells in the mouse mammary tumor system.
    Lane MA; Roubinian J; Slomich M; Trefts P; Blair PB
    J Immunol; 1975 Jan; 114(1 Pt 1):24-9. PubMed ID: 46242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenic macrophages from tumor-bearing mice co-expressing MAC-1 and MAC-2 antigens exert immunoregulatory functions via two distinct mechanisms.
    Watson GA; Fu YX; Lopez DM
    J Leukoc Biol; 1991 Feb; 49(2):126-38. PubMed ID: 1991996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Target cell - substratum interaction. I. Effect of primed lymphocytes on a rat mammary adenocarcinoma tumor cell line.
    David GS; Wiglesworgh CM
    Immunol Commun; 1978; 7(3):337-52. PubMed ID: 77840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro detection of immune responses to MTV-induced mammary tumors: qualitative differences in response detected by time studies.
    Blair PB; Lane MA
    J Immunol; 1975 Jan; 114(1 Pt 1):17-23. PubMed ID: 163276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity to murine sarcoma virus induced tumours. IV. Direct cellular cytolysis of 51Cr labelled target cells in vitro and analysis of blocking factors which modulate cytotoxicity.
    Gorczynski RM; Knight RA
    Br J Cancer; 1975 Apr; 31(4):387-404. PubMed ID: 50851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro detection of cytotoxic cellular immunity against tumor-specific antigens by a radioisotopic technique.
    Jagarlamoody SM; Aust JC; Tew RH; McKhann CF
    Proc Natl Acad Sci U S A; 1971 Jun; 68(6):1346-50. PubMed ID: 4331089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.